犬细小病毒四川株的分离与鉴定

为更好地了解我国细小病毒流行情况,笔者从四川农大动物医院采集5份患出血性肠炎犬的粪便,通过猫肾细胞(F81)传代培养后,成功分离到两株犬细小病毒。对两株病毒进行病毒形态学、理化学、血凝试验、PCR鉴定与分子生物学系统鉴定后,证实分离株是犬细小病毒,通过VP2结构蛋白测序分析表明,新分离到的两株细小病毒抗原型分别属于CPV-2a和CPV-2b。     

犬细小病毒新2b型分离株的分离鉴定

为了更好的了解我国东北地区犬细小病毒的流行情况,采用F81细胞从来自长春某宠物医院疑似患有肠炎的犬粪便样品中分离出1株病毒,经形态学、血清学、动物回归试验和分子生物学鉴定,分离的病毒为犬细小病毒new CPV-2b型,命名为CPV JL13-1。对该病毒主要结构蛋白VP2基因进行克隆测序和基因进化分析表明,CPV JL13-1分离株VP2基因与GenBank上提交的其他41株犬细小病毒株核苷酸和氨基酸均有较高的同源性,分别为98.6%~99.5%和97.6%~99.5%,其中核苷酸和氨基酸同源性最高的均为B-2004株。本研究为犬细小病毒分子流行病学调查和疫苗的研究奠定基础。     

犬细小病毒四川株的分离与鉴定

采集5份患出血性肠炎犬的粪便,通过猫肾细胞(F81)传代培养后,成功分离到2株病毒。对2株病毒进行病毒形态学、理化学、血凝试验、PCR鉴定与分子生物学系统鉴定后,证实分离株是犬细小病毒,通过VP2结构蛋白测序分析表明,新分离到的2株细小病毒抗原型分别属于CPV-2a和CPV-2b。     

犬细小病毒的分离鉴定

正犬细小病毒(canine parvovirus,CPV)属于自主复制性细小病毒科,细小病毒属,它能引起急性肠炎,白细胞减少,呕吐以及幼犬的心肌炎等病症。为了更好的了解犬细小病毒病在我国的流行和变异情况,通过对宠物医院疑似犬细小病毒病例进行病毒分离,分离出一株犬细小病毒,经过形态学、生物学以子病毒学等鉴定,证明分离出的毒株为细小病毒。     

一株新分离犬细小病毒灭活疫苗的制备及免疫效果研究

JL0911株犬细小病毒是由军事兽医研究所流行病与病毒病防控技术实验室分离得到的一株新型犬细小病毒,其主要抗原位点上的氨基酸序列较国内先前分离到的其他株有较大差异,不能被归入目前已有的CPV-2a、CPV-2b、CPV-2c三个类型。本研究旨在利用JL0911株犬细小病毒研制灭活疫苗,并评价其免疫原性。试验采用10^5.5 TCID₅₀/mL的犬细小病毒JL0911,以甲醛灭活后,加入1/4体积的纳米佐剂,制备了犬细小病毒灭活疫苗。取1.5 mL上述疫苗,通过肌肉注射免疫普通家犬,免疫前后不同时间均采集血清,在F81细胞系上测定犬细小病毒的中和抗体。结果显示,免疫后14 d,试验犬血中细小病毒中和抗体效价较免疫前有显著提高,最高可由0提高至2⁹,表明本试验分离的JL0911株犬细小病毒具有生产犬细小病毒灭活疫苗的潜在价值。     

犬用细小病毒自然弱毒株的分离、鉴定和免疫研究

应用猫肾传代细胞F81系,以同步接毒和带毒传代的方法。先后从50份犬、15份狐、75份貉和8份狮、虎、豹病料中分碍15株犬细小病毒(cpv)、3株貉细小病毒和6株猫泛白细胞减少症病毒,未分到狐细小病毒。通过人工感染试验,从中挑选到1株对犬和本动物无致病性、但具有良好免疫原性的细小病毒——貉细小病毒CR86106株。经核酸型、形态学、理化学、生物学特性试验以及与CPV核酸酶切图比较试验等系统鉴定,CR86106株病毒为1株与CPV特性基本相同,但也存在有一定差别的小DNA病毒。免疫试验和田间试验证明,CR86106株病毒遗传性稳定;对母源抗体干扰具有较强的抵抗力;免疫接种犬虽可随粪便排出少量原接种病毒,但不会使同居犬感染发病;试验犬经两次疫苗接种后攻毒,可获得完全保护,且不会随粪便排出强毒。累计免疫军、警犬3320只,全部安全,保护率达99.28％。     

犬细小病毒黑龙江株(CPV-YN)的分离、鉴定及致弱的研究

为研制犬细小病毒(CPV)致弱疫苗,本研究通过将犬的组织样品接种CRFK细胞进行病毒分离,并对分离毒株进行了一系列鉴定。鉴定结果显示,分离的病毒在CRFK细胞上可产生明显的细胞病变(CPE),并且电镜下可以观察到典型的细小病毒粒子;HA效价可达到1∶256。回归动物试验显示该分离株可导致犬出现明显的CPV感染症状,PCR鉴定也进一步确定所分离的病毒为CPV(命名为CPV-YN株)。将CPV-YN株接种CRFK细胞连续传代至110代,在传代过程中,病毒的滴度逐渐提高,由初始的105.5 TCID50/0.1 mL逐渐增加到107.1 TCID50/0.1 mL。同时,CPV对犬的致病力逐渐降低。免疫效力试验结果表明,CPV-YNR可以对用同源强毒攻击的犬提供免疫保护作用,可作为理想的疫苗候选病毒株。     

犬细小病毒DD株的分离鉴定和VP2基因序列分析

本实验室对从疑似犬细小病毒感染的发病犬分离的病毒采用同步培养法接种猫肾细胞（CRFK）增殖,通过PCR试验、IFA试验和VP2基因测序分析等方法进行鉴定并分型,获得一株犬细小病毒强毒株,命名为CPV-DD株。对分离病毒进行PCR扩增,可扩增出特异性DNA片段（1 163 bp）;盲传至第6代时,病毒液的HA效价为1∶1...     

14株北京地区犬细小病毒分离毒株的VP2、NS1基因序列分析

从北京地区疑似细小病毒感染的犬粪拭子中成功分离鉴定出14株犬细小病毒（CPV）毒株,并对其完整的VP2和NS1基因进行了序列分析。结果表明,鉴定到的14株CPV毒株中,7株为New CPV-2a型,7株为CPV-2c型。此外,NS1的19、33、293、588、624和656位氨基酸以及VP2的13、574位氨基酸为新鉴定的氨基酸突变位点。基于VP2、NS1基因的系统进化分析表明,大部分的New CPV-2a型和CPV-2c型毒株与广西南宁和吉林长春地区的分离毒株亲缘关系密切,说明本次分离毒株与广西或吉林地区分离毒株具有相同的起源。本研究为更好地开展犬细小病毒流行病学调查提供了有益借鉴,也为深入研究犬细小病毒变异和传播的分子机制奠定了基础。     

犬细小病毒上海株的分离与鉴定

为研究上海地区犬细小病毒的流行情况,采集疑似犬细小病毒感染犬的肠内容物,无菌处理病料后同步接种猫肾脏F81细胞,盲传至第5代出现细胞病变,从肠内容物中分离出1株病毒。采用细胞培养病变观察、病毒形态学鉴定、直接免疫荧光抗体检测、细胞敏感谱试验、红细胞凝集试验、部分理化特性鉴定和VP2序列的测定等方法,鉴定分离株为犬细小病毒,命名为CPV-2/canine/Shanghai/01/2018。该病毒的TCID50为105.3/0.1 mL,血凝效价为28,病毒测得VP2基因序列的全长为1 755 bp。与已知序列比较,其核苷酸同源性为98.3%～99.1%,氨基酸同源性为97.3%～99.3%。对其VP2基因的氨基酸序列进行分析,确定该细小病毒属于CPV-2c亚型。研究提示,上海地区CPV存在不同的基因亚型,在进行疫苗免疫时应当选择正确的疫苗株。     

犬细小病毒病原分离及分型研究

为查明4份疑为患细小病毒病军犬的病原及其特性,为进一步的免疫研究奠定基础,本试验将4份送检的犬肠道内容物过滤后分别接种猫肾细胞(F81),培养5 d后,未出现细胞病变的带毒盲传。同时提取病料的总DNA,用犬细小病毒的VP2特异性引物进行PCR扩增,PCR阳性产物克隆至pMD18-T载体测序,并与已知参考毒株序列进行比对及系统发育分析。测序结果表明,用F81细胞分离到4株细小病毒;经VP2基因比对分型结果表明,4株细小病毒毒株均属CPV-2a,分别命名为CPV-JQ、CPV-CM、CPV-M和CPV-KM。     

Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper,canine parvovirus infection and rabies

Wild dogs Lycaon pictuis (n = 8) were vaccinated 4 times against canine distemper (n = 8) (initially with inactivated and subsequently with live attenuated strains of canine distemper) and canine parvovirus infection (n = 8) over a period of 360 days. Four of the wild dogs were also vaccinated 3 times against rabies using a live oral vaccine and 4 with an inactivated parenteral vaccine. Commercially-available canine distemper, canine parvovirus and parenteral rabies vaccines, intended for use in domestic dogs, were used. None of the vaccinated dogs showed any untoward clinical signs. The inactivated canine distemper vaccine did not result in seroconversion whereas the attenuated live vaccine resulted in seroconversion in all wild dogs. Presumably protective concentrations of antibodies to canine distemper virus were present in all wild dogs for at least 451 days. Canine parvovirus haemagglutination inhibition titres were present in all wild dogs prior to the administration of vaccine and protective concentrations persisted for at least 451 days. Vaccination against parvovirus infection resulted in a temporary increase in canine parvovirus haemagglutination inhibition titres in most dogs. Administration of both inactivated parenteral and live oral rabies vaccine initially resulted in seroconversion in 7 of 8 dogs. These titres, however, dropped to very low concentrations within 100 days. Booster administrations resulted in increased antibody concentrations in all dogs. It was concluded that the vaccines were safe to use in healthy subadult wild dogs and that a vaccination protocol in free-ranging wild dogs should at least incorporate booster vaccinations against rabies 3-6 months after the first inoculation.     

潍坊市犬奇异变形杆菌分离鉴定及耐药性检测

奇异变形杆菌为人兽共患病原菌,多为继发感染.本研究从潍坊地区宠物医院的犬瘟热患病犬眼鼻分泌物和犬细小病毒感染患病犬直肠粪便中,共采集样品39份,进行奇异变形杆菌分离鉴定和耐药性检测.结果显示:分离鉴定出11株奇异变形杆菌,分离率为28.20％,其中犬细小病毒感染犬的奇异变形杆菌分离率为47.37％;16S rRNA序列...     

犬瘟热,猫细小病毒,犬腺病毒弱毒株的理化特性及生物学试验

以鸡胚成纤维细胞（ＣＥＦ）、猫肾传代细胞（ＣＲＦＫ）、狗肾传代细胞（ＭＤＣＫ）从引进的疫苗中分别分离到犬瘟热ＣＤＶ－Ａ株、猫细小病毒ＦＰＶ株、犬腺病毒ＣＡＶ１株。对三个弱毒株的细胞病变规律,形态特征,病毒滴度,理化特性,核酸型,血清学交叉反应,本动物的安全性及免疫原性等内容进行了试验。鉴定结果表明,３个弱毒株均可作为制苗用毒种     

Serologic response of maned wolves (Chrysocyon brachyurus) to canine and canine parvovirus vaccination distemper virus.

This study evaluated the immune response of 47 (22 males, 25 females) captive maned wolves (Chrysocyon brachyurus) to modified-live canine parvovirus and canine distemper virus (Onderstepoort and Rockborn strains) vaccines. Sera were collected from 33 adults and 14 pups, including five free-ranging pups captured at 1 yr of age or younger. All the adults and four captive-born pups had been vaccinated prior to this first blood collection. Virus neutralization and hemagglutination-inhibition assays were performed for quantitating antibodies against canine distemper and canine parvovirus, respectively. Distemper antibody titers > or = 100 were present in 57% of adults and 14% of pups. All adults and 29% of pups had parvovirus antibody titers > or = 80. After vaccination, 72% of the wolves developed antibody titers > or = 100 against distemper and 98% developed titers > or = 80 against parvovirus. Both vaccines used were safe and immunogenic to juvenile and adult maned wolves, regardless of prior vaccination history.     

Analysis of Clone and Prokaryotic Expression of Canine Parvovirus VP2 Gene

The study was aimed to investigate the epidemic situation of canine parvovirus in Hebei and Gansu provinces.VP2 protein was expressed by prokaryotic system and polyclonal antibodies were prepared, which provided a basis for the further researches on pathogenesis and therapy of canine parvovirus.Virus genomic DNA was extracted from 10 epidemic materials of suspected infected dogs and VP2 gene was amplified.The target fragments of VP2 gene were cloned to pET-30a vector after sequencing and analysis, then the positive expression plasmids were transformed into E.coli BL21 (DE3) cell.Polyclonal antibodies were prepared by immunizing guinea pigs with the SDS-PAGE identification of purified protein.The genetic analysis results showed that the VP2 gene was successfully cloned and 80% samples were belonged to CPV-2a and 20% samples were belonged to CPV-2b.The isolated strains of the test and part of China strains were gathered into a branch which had certain distance with strains of Korea and USA, and that had low homology with strains of Italy.SDS-PAGE results indicated that the recombinant protein with a molecular weight of 70 ku was expressed by prokaryotic system.Western blotting results showed that the recombinant protein had good immuneoreactivity and immunogenicity.The study indicated that CPV-2a was the predominant gene type in Hebei and Gansu provinces, meanwhile VP2 protein expressed by prokaryotic system had good antigenicity.This research provided a basis for the future study of the prevention and control of canine parvovirus.     

免疫金电镜技术检测犬细小病毒免疫球蛋白

本文应用免疫金电镜技术检测犬细小病毒免疫球蛋白（Ｉｇ）。检测结果证明驴抗犬细小病毒所产生的Ｉｇ对犬细小病毒具有较强的特异性反应。因此认为,第四军医大学动物保健品研制中心所制备的免疫球蛋白对犬细小病毒性肠炎和心肌炎具有良好的治疗和预防作用。     

犬细小病毒病发病情况调查与流行分析

对吉林市2009—2010年犬细小病毒病的发病情况进行了调查和分析。收集9个动物医院2年接诊的5684例疑似犬细小病毒病犬,通过临床检查及实验室诊断,确诊4124例患犬发生不同类型的犬细小病毒病。研究表明,本病发生多以肠炎型为主,占总发病数的49.64%;犬品种影响犬细小病毒病的发生,纯种犬的发病率最高,占62.85%,土种犬发病率最低,占11.99%;1~3月龄的幼犬多发,占发病数的65.11%;一年四季均有发病,多发于气温骤变的11~12月和2~3月;免疫次数也影响了犬细小病毒病的发生,每年2次免疫可以显著降低犬细小病毒病的发生。因此,选择高质量的疫苗,增加免疫次数,选择合理的饲养环境,加强多发季节和多发年龄段对犬的保护是减少本病发生的关键。